Gennex Laboratories Ltd — Board Meeting, 14-08-2025: Board Meeting

Gennex Laboratories Limited's Board has approved the financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs 25.64 Cr and a net profit of Rs 4.15 Cr. For consolidated results, revenue stood at Rs 34.18 Cr with a net profit of Rs 5.02 Cr. These figures were subject to a limited review by statutory auditors. This update provides investors key insights into the company's operational performance and profitability, reflecting its business health primarily in the Bulk Drugs, Biotech Products, and Intermediates segment.